首页> 外文OA文献 >Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas
【2h】

Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas

机译:cyclin D1表达在头颈部鳞状细胞癌无瘤手术切缘中的预后价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Conclusion: It was proved that cyclin D1-positive status in surgical margins was an independent prognostic indicator of local recurrence. The expression of cyclin D1 in tumor-free surgical margins may better predict local recurrence in patients with head and neck squamous cell carcinoma (HNSCC) after surgical treatment with curative intent. Objective: This retrospective study aimed to determine the prognostic indicators for local recurrence in HNSCC. Methods: A total of 116 HNSCC patients who underwent surgical treatment with curative intent and had histopathologically tumor-free margins were eligible for this study. The expression of p53 and cyclin D1 was assessed by immunohistochemical staining in surgical margins as well as in tumor specimens. Results: In all, 63 patients (54.3%) had p53-positive tumor specimens and 34 patients (29.3%) had p53-positive margins. Seventy-six patients (65.6%) had cyclin D1-positive tumor specimens and 54 patients (46.6%) had cyclin D1-positive margins. A significant difference in local control rates was observed between patients with cyclin D1-positive and -negative margins (77.2% vs 91.5%, log rank test, p = 0.0139). Multivariate Cox proportional hazards testing indicated that the hazard ratio of cyclin D1-positive margins for local recurrence was 4.58 (95% confidence interval 1.14–21.69, p = 0.0304).
机译:结论:已证明手术边缘细胞周期蛋白D1阳性是局部复发的独立预后指标。 Cyclin D1在无肿瘤手术切缘中的表达可以更好地预测头颈部鳞状细胞癌(HNSCC)患者经过根治性手术治疗后的局部复发。目的:这项回顾性研究旨在确定HNSCC局部复发的预后指标。方法:总共116名接受根治性手术治疗且组织病理学无肿瘤切缘的HNSCC患者符合本研究的条件。通过免疫组织化学染色在手术切缘和肿瘤标本中评估p53和cyclin D1的表达。结果:总共63例患者(54.3%)的p53阳性肿瘤标本和34例患者(29.3%)的p53阳性切缘。 76例患者(65.6%)的细胞周期蛋白D1阳性标本和54例患者(46.6%)的细胞周期蛋白D1阳性切缘。 Cyclin D1阳性和阴性患者的局部控制率有显着差异(77.2%vs 91.5%,对数秩检验,p = 0.0139)。多元Cox比例风险测试表明,Cyclin D1阳性切缘局部复发的风险比为4.58(95%置信区间1.14–21.69,p = 0.0304)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号